CIK 0000849146
- Accelerated filer
- Smaller reporting company
Lifevantage Corp
Sign in to watch- Ticker
- LFVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 900224471
- Phone
- +1 801-432-9000
- Business address
- 3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
- Former names
- LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
- Open-market buys, last 90 days
- $6,071
- in 1 filing
- Open-market sales, last 90 days
- $104,510
- in 2 filings
Net −$98,439. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-07 | Aure Carl Chief Financial Officer | Grant or award | +35,749 | 191,784 | ||
| 2026-10-07 | Aure Carl Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +53,623 | 53,623 | ||
| 2026-10-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −460 | $6.24 | $3K | 156,035 |
| 2026-09-10 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −1,869 | $6.37 | $12K | 156,495 |
| 2026-07-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −1,361 | $6.25 | $9K | 155,554 |
| 2026-04-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −1,527 | $4.20 | $6K | 156,915 |
| 2026-01-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −1,527 | $6.16 | $9K | 158,442 |
| 2025-10-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −1,361 | $9.56 | $13K | 159,969 |
| 2025-08-31 | Aure Carl Chief Financial Officer | Exercise or conversion | +14,792 | 159,054 | ||
| 2025-08-31 | Aure Carl Chief Financial Officer | Exercise or conversion | +18,886 | 177,940 | ||
| 2025-08-31 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −16,610 | $13.10 | $218K | 161,330 |
| 2025-08-31 | Aure Carl Chief Financial Officer | Exercise or conversion · Performance Restricted Stock Units | −14,792 | 4,931 | ||
| 2025-08-31 | Aure Carl Chief Financial Officer | Exercise or conversion · Performance Restricted Stock Units | −18,886 | 9,443 | ||
| 2025-08-26 | Aure Carl Chief Financial Officer | Grant or award | +10,241 | 143,544 | ||
| 2025-08-26 | Aure Carl Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +15,361 | 15,361 | ||
| 2025-07-01 | Aure Carl Chief Financial Officer | Exercise or conversion | +2,401 | 136,049 | ||
| 2025-07-01 | Aure Carl Chief Financial Officer | Sale | −2,746 | $13.39 | $37K | 133,303 |
| 2025-07-01 | Aure Carl Chief Financial Officer | Exercise or conversion · Performance Restricted Stock Units | −2,401 | 0 | ||
| 2025-04-01 | Aure Carl Chief Financial Officer | Exercise or conversion | +2,401 | 134,807 | ||
| 2025-04-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −2,749 | $15.79 | $43K | 132,058 |
Page 1 of 3 · 48 trades